A retrospective comparative study of prednisolone use in antagonist co-treated assisted reproductive technology cycles for patients with good prognosis

dc.contributor.authorÖzmen, Batuhan
dc.contributor.departmentTıp Fakültesitr_TR
dc.date.accessioned2020-12-04T09:02:56Z
dc.date.available2020-12-04T09:02:56Z
dc.date.issued2018
dc.description.abstractObjective: To investigate the impact of peri-implantation prednisolone use and its duration in antagonist co-treated assisted reproductive technology (ART) cycles of patients with good prognosis. Materials and methods: Infertile patients treated with gonadotropin-releasing hormone antagonist protocol between January 2010 and June 2013 were included. The patients in group A (n=196) received no prednisolone. The patients in groups B (n=397) and C (n=371) received 5 mg oral prednisolone daily, for 4 and 12 days following embryo transfer, respectively. The main outcome parameter was live birth rate. Results: The ages of the groups were 30.1±4.6, 31.5±4.5, and 30.9±4.7 years, respectively (p=0.163). There was no statistically significant difference between the groups regarding cycle characteristics. Implantation rates were 20.7%, 24.6%, and 23.8%, respectively (p=0.163). Miscarriage rates were 1.5%, 3.5%, and 3.2%, respectively (p=0.859). Live birth rates were 28.7%, 29.3%, and 32.8%, respectively (p=0.482). Conclusion: Empiric prednisolone administration during the peri-implantation period does not seem to have beneficial effects in ART cycles of patients with good prognosis.tr_TR
dc.description.indexPubmed
dc.identifier.endpage151tr_TR
dc.identifier.issue3tr_TR
dc.identifier.startpage147tr_TR
dc.identifier.urihttps://doi.org/10.4274/tjod.12244tr_TR
dc.identifier.urihttp://hdl.handle.net/20.500.12575/72532
dc.identifier.volume15tr_TR
dc.language.isoentr_TR
dc.relation.isversionof10.4274/tjod.12244tr_TR
dc.relation.journalTurk J Obstet Gynecol .tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıtr_TR
dc.subjectAssisted reproductive technologytr_TR
dc.subjectglucocorticoidtr_TR
dc.subjectgonadotropin-releasing hormone antagonisttr_TR
dc.titleA retrospective comparative study of prednisolone use in antagonist co-treated assisted reproductive technology cycles for patients with good prognosistr_TR
dc.typeArticletr_TR

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
tjod-15-147.pdf
Size:
169.24 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.62 KB
Format:
Item-specific license agreed upon to submission
Description: